Das Wichtigste zur Therapie des Harnblasenkarzinoms
Crossref DOI link: https://doi.org/10.1007/s15006-022-1138-y
Published Online: 2022-06-17
Published Print: 2022-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Ebner, Benedikt
Eismann, Lennert
Volz, Yannic
Bischoff, Robert
Stief, Christian G.
Schulz, Gerald Bastian
Text and Data Mining valid from 2022-06-01
Version of Record valid from 2022-06-01
Article History
First Online: 17 June 2022
Interessenkonflikt
: Keiner